Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 8907314, 7 pages
http://dx.doi.org/10.1155/2016/8907314
Clinical Study

The Impact of Obstructive Sleep Apnoea and Nasal Continuous Positive Airway Pressure on Circulating Ischaemia-Modified Albumin Concentrations

1Faculty of Medicine, Department of Pulmonary Medicine, Bulent Ecevit University, 67600 Zonguldak, Turkey
2Faculty of Medicine, Department of Biochemistry Zonguldak, Bulent Ecevit University, 67600 Zonguldak, Turkey
3Faculty of Medicine, Department of Otolaryngology, Bulent Ecevit University, 67600 Zonguldak, Turkey
4Faculty of Medicine, Department of Biostatistics, Bulent Ecevit University, 67600 Zonguldak, Turkey

Received 14 September 2015; Revised 24 December 2015; Accepted 30 December 2015

Academic Editor: Fumio Tsuji

Copyright © 2016 Firat Uygur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. ASDA-Diagnostic Classification Steering Committee, The International Classification of Sleep Disorders: Diagnostic and Coding Manual, Allen Press, Lawrence, Ks, USA, 2nd edition, 1997.
  2. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr, “The occurrence of sleep-disordered breathing among middle-aged adults,” The New England Journal of Medicine, vol. 328, no. 17, pp. 1230–1235, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Arias, F. García-Río, A. Alonso-Fernández, I. Martínez, and J. Villamor, “Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study,” European Heart Journal, vol. 27, no. 9, pp. 1106–1113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Mooe, T. Rabben, U. Wiklund, K. A. Franklin, and P. Eriksson, “Sleep-disordered breathing in men with coronary artery disease,” Chest, vol. 109, no. 3, pp. 659–663, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. F. J. Nieto, T. B. Young, B. K. Lind et al., “Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study,” The Journal of the American Medical Association, vol. 283, no. 14, pp. 1829–1836, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Peker, J. Hedner, J. Norum, H. Kraiczi, and J. Carlson, “Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 2, pp. 159–165, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Gilat, S. Vinker, I. Buda, E. Soudry, M. Shani, and G. Bachar, “Obstructive sleep apnea and cardiovascular comorbidities: a large epidemiologic study,” Medicine, vol. 93, no. 9, p. e45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Can, Ş. Açikgöz, G. Mungan et al., “Serum cardiovascular risk factors in obstructive sleep apnea,” Chest, vol. 129, no. 2, pp. 233–237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. L. S. Doherty, J. L. Kiely, V. Swan, and W. T. McNicholas, “Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome,” Chest, vol. 127, no. 6, pp. 2076–2084, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Marin, S. J. Carrizo, E. Vicente, and A. G. N. Agusti, “Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study,” The Lancet, vol. 365, no. 9464, pp. 1046–1053, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Lavie and P. Lavie, “Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link,” European Respiratory Journal, vol. 33, no. 6, pp. 1467–1484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Dyugovskaya, P. Lavie, and L. Lavie, “Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 7, pp. 934–939, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Alonso-Fernández, F. García-Río, M. A. Arias et al., “Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial,” Thorax, vol. 64, no. 7, pp. 581–586, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Bar-Or, E. Lau, and J. V. Winkler, “A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report,” Journal of Emergency Medicine, vol. 19, no. 4, pp. 311–315, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. D. C. Gaze, “Ischemia Modified Albumin: a novel biomarker for the detection of cardiac ischemia,” Drug Metabolism and Pharmacokinetics, vol. 24, no. 4, pp. 333–341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. S. Talwalkar, M. Bon Homme, J. J. Miller, and R. J. Elin, “Ischemia modified albumin, a marker of acute ischemic events: a pilot study,” Annals of Clinical and Laboratory Science, vol. 38, no. 2, pp. 132–137, 2008. View at Google Scholar · View at Scopus
  17. D. Bar-Or, G. Curtis, N. Rao, N. Bampos, and E. Lau, “Characterization of the Co2+ and Ni2+ binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia,” European Journal of Biochemistry, vol. 268, no. 1, pp. 42–47, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Zhong, N. Wang, H. Xu, X. Hou, P. Xu, and Z. Zhou, “Ischemia-modified albumin in stable coronary atherosclerotic heart disease: clinical diagnosis and risk stratification,” Coronary Artery Disease, vol. 23, no. 8, pp. 538–541, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Van Belle, J. Dallongeville, E. Vicaut, A. Degrandsart, C. Baulac, and G. Montalescot, “Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study,” American Heart Journal, vol. 159, no. 4, pp. 570–576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Kazanis, M. Dalamaga, C. Nounopoulos et al., “Ischemia modified albumin, high-sensitivity c-reactive protein and natriuretic peptide in patients with coronary atherosclerosis,” Clinica Chimica Acta, vol. 408, no. 1-2, pp. 65–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Refaai, R. W. Wright, C. A. Parvin, A. M. Gronowski, M. G. Scott, and C. S. Eby, “Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery,” Clinica Chimica Acta, vol. 366, no. 1-2, pp. 264–268, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Turedi, A. Gunduz, A. Mentese et al., “Value of ischemia-modified albumin in the diagnosis of pulmonary embolism,” The American Journal of Emergency Medicine, vol. 25, no. 7, pp. 770–773, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Özdemir, A. Kiyici, A. Balevi, I. Mevlitoǧlu, and C. Peru, “Assessment of ischaemia-modified albumin level in patients with psoriasis,” Clinical and Experimental Dermatology, vol. 37, no. 6, pp. 610–614, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Abboud, J. Labreuche, E. Meseguer et al., “Ischemia-modified albumin in acute stroke,” Cerebrovascular Diseases, vol. 23, no. 2-3, pp. 216–220, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Borderie, Y. Allanore, C. Meune, J. Y. Devaux, O. G. Ekindjian, and A. Kahan, “High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis,” Clinical Chemistry, vol. 50, no. 11, pp. 2190–2193, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. M. F. Duarte, J. B. T. Rocha, R. N. Moresco et al., “Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia,” Clinical Biochemistry, vol. 42, no. 7-8, pp. 666–671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Can, S. Demirtas, O. Polat, and A. Yildiz, “Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma,” Emergency Medicine Journal, vol. 23, no. 7, pp. 537–539, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Can, F. Varlibas, B. Guven, O. Akhan, and G. A. Yuksel, “Ischemia modified albumin and plasma oxidative stress markers in Alzheimer's disease,” European Neurology, vol. 69, no. 6, pp. 377–380, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. Ş. Açikgöz, N. Edebali, F. Barut et al., “Ischemia modified albumin increase indicating cardiac damage after experimental subarachnoid hemorrhage,” BMC Neuroscience, vol. 15, article 33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Ozben, N. Huseyinoglu, F. Hanikoglu et al., “Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea,” European Journal of Clinical Investigation, vol. 44, no. 11, pp. 1045–1052, 2014. View at Publisher · View at Google Scholar
  31. L.-X. Yang, S.-G. Ma, H. Liu, and W. Xu, “Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels,” Clinics, vol. 68, no. 7, pp. 968–973, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. M. W. Johns, “A new method for measuring daytime sleepiness: the Epworth sleepiness scale,” Sleep, vol. 14, no. 6, pp. 540–545, 1991. View at Google Scholar · View at Scopus
  33. R. B. Berry, R. Brooks, C. E. Gamaldo, S. M. Harding, C. L. Marcus, and B. V. Vaughn, The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.0., American Academy of Sleep Medicine, Darien, Ill, USA, 2012, http://www.aasmnet.org.
  34. L. Lavie, “Obstructive sleep apnoea syndrome—an oxidative stress disorder,” Sleep Medicine Reviews, vol. 7, no. 1, pp. 35–51, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Barceló, F. Barbé, M. de la Peña et al., “Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment,” European Respiratory Journal, vol. 27, no. 4, pp. 756–760, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Roy, J. Quiles, D. C. Gaze, P. O. Collinson, J. C. Kaski, and G. F. Baxter, “Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin,” Heart, vol. 92, no. 1, pp. 113–114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. L. C. Cichota, R. N. Moresco, M. M. M. F. Duarte, and J. E. P. da Silva, “Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease,” Journal of Clinical Laboratory Analysis, vol. 22, no. 1, pp. 1–5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. O. Aydin, H. Y. Ellidag, E. Eren, F. Kurtulus, A. Yaman, and N. Yilmaz, “Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis,” Biochemia Medica, vol. 24, no. 3, pp. 383–389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Altunoglu, G. Guntas, F. Erdenen et al., “Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease,” Geriatrics & Gerontology International, vol. 15, no. 7, pp. 872–880, 2015. View at Publisher · View at Google Scholar
  40. Y. Guo, L. Pan, D. Ren, and X. Xie, “Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis,” Sleep and Breathing, vol. 17, no. 2, pp. 495–503, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Shimizu, K. Chin, T. Nakamura et al., “Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome,” Thorax, vol. 57, no. 5, pp. 429–434, 2002. View at Google Scholar
  42. K. Ishida, M. Kato, Y. Kato et al., “Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea,” Chest, vol. 136, no. 1, pp. 125–129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Mermigkis, I. Bouloukaki, D. Mermigkis et al., “CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role?” Sleep and Breathing, vol. 16, no. 3, pp. 813–819, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Colish, J. R. Walker, N. Elmayergi et al., “Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI,” Chest, vol. 141, no. 3, pp. 674–681, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Kohler, L. Ayers, J. C. T. Pepperell et al., “Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial,” Thorax, vol. 64, no. 1, pp. 67–73, 2009. View at Publisher · View at Google Scholar · View at Scopus